ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eiser, N
Right arrow Articles by Quirk, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eiser, N
Right arrow Articles by Quirk, F
Eur Respir J 1997; 10: 1581-1584
Copyright © ERS Journals Ltd 1997


Original Articles

Effects of psychotherapy in moderately severe COPD: a pilot study

N Eiser, C West, S Evans, A Jeffers, and F Quirk

Anxiety is common in the "pink puffer" syndrome associated with chronic obstructive pulmonary disease (COPD). The degree of anxiety correlates well with perceived dyspnoea. This pilot study examines the effect of group psychotherapy on anxiety, exercise tolerance, dyspnoea and quality of life. Ten patients with moderately severe, stable COPD (mean forced expiratory volume in one second (FEV1)-1.15 L) had six 90 min sessions of cognitive and behavioural psychotherapy at weekly intervals. Patients completed the Hospital Anxiety and Depression Scale (HADS), Medical Research Council Questionnaire (MRCQ) and St George's Respiratory Questionnaires (SGRQ), 1 week before and after therapy. FEV1, forced vital capacity (FVC), slow vital capacity (SVC), blood gas tensions and 6 min walking distance (6MWD) were measured. Eight control patients attended weekly for lung function and 6MWD for 6 weeks, but had no psychotherapy. Mean baseline HADS score was significantly higher in the psychotherapy group (12) than in controls (7), but otherwise there were no differences in lung function, blood gas tensions, 6MWD, or the other questionnaire scores between groups. After treatment, the physiological and psychological parameters where unchanged in both groups with the exception of the mean 6MWD, which had improved in the psychotherapy group only, from 351 to 423 m (p<0.001), an increase of 24%. Three months after treatment, the 6MWD was still 16% above the baseline value (p=0.02). In conclusion, six sessions of cognitive and behavioural psychotherapy produced a sustained improvement in exercise tolerance in a group of 10 anxious patients with severe chronic obstructive pulmonary disease, without any change in anxiety scores on the Hospital Anxiety and Depression Scale. Further studies of more prolonged, intensive psychotherapy would establish whether better symptom and quality of life scores accompany more dramatic increases in exercise tolerance in "pink puffers".


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
M Baron, E Sutton, M Hudson, B Thombs, J Markland, J Pope, D Robinson, N Jones, P Docherty, M Abu-Hakima, et al.
The relationship of dyspnoea to function and quality of life in systemic sclerosis
Ann Rheum Dis, May 1, 2008; 67(5): 644 - 650.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. G. Collins, W. E. Langbein, L. Fehr, S. O'Connell, C. Jelinek, E. Hagarty, L. Edwards, D. Reda, M. J. Tobin, and F. Laghi
Can Ventilation-Feedback Training Augment Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease?
Am. J. Respir. Crit. Care Med., April 15, 2008; 177(8): 844 - 852.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. Guell, V. Resqueti, M. Sangenis, F. Morante, B. Martorell, P. Casan, and G. H. Guyatt
Impact of Pulmonary Rehabilitation on Psychosocial Morbidity in Patients With Severe COPD.
Chest, April 1, 2006; 129(4): 899 - 904.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
N F Schlecht, K Schwartzman, and J Bourbeau
Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease
Chronic Respiratory Disease, October 1, 2005; 2(4): 183 - 191.
[Abstract] [PDF]


Home page
Eur Respir JHome page
J.R. Curtis and D.L. Patrick
The assessment of health status among patients with COPD
Eur. Respir. J., June 1, 2003; 21(41_suppl): 36S - 45s.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Ferrer, C. Villasante, J. Alonso, V. Sobradillo, R. Gabriel, G. Vilagut, J.F. Masa, J.L. Viejo, C.A. Jimenez-Ruiz, and M. Miravitlles
Interpretation of quality of life scores from the St George's Respiratory Questionnaire
Eur. Respir. J., March 1, 2002; 19(3): 405 - 413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. MATHUR, I. JANE COX, A. OATRIDGE, D. T. SHEPHARD, R. J. SHAW, and S. D. TAYLOR-ROBINSON
Cerebral Bioenergetics in Stable Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., December 1, 1999; 160(6): 1994 - 1999.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
Pulmonary Rehabilitation---1999
Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1666 - 1682.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the European Respiratory Society.